About


AstraZeneca established the BioVentureHubin 2014 as an open innovation ecosystem to further strengthen competitiveness and dynamism in the life science industry.The BioVentureHub is based on an innovative public-private-partnership model and is located at the heart of AstraZeneca Gothenburg. It gives emerging life science companies and academic groups a unique opportunity to co-locate with and tap into the power of AstraZeneca’s world-class scientists and state of the art lab facilities and infrastructure, and with each other.


Meet the team



Facts & figures

An innovative way to access life science expertise and infrastructure

 

Established

2014

30

companies

10

alumni

5,066 m2 

of office and laboratory space

1

academic group

180

people




Company satisfaction index

 

 

Drugs              

Devices             

Diagnostics              

Digital health




Attracting investment and talent

 

Significant capital raised

78

clinical trials

61

new recruitments

4

countries




 

 

>25

between BVH companies

78

between BVH companies and the life science industry

>20

between BVH companies and AstraZeneca




Catalyzing innovation & knowledge transfer

Sector convergence.  Access to innovation programs: AstraZeneca / IBM /Mölnlycke/SMEs / Academia